The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 108 (1-2) , 136-146
- https://doi.org/10.1016/s0165-5728(00)00265-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxideInternational Journal of Immunopharmacology, 1995
- Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple SclerosisImmunological Reviews, 1995
- Expression and regulation of human and rat phosphodiesterase type IV isogenesFEBS Letters, 1994
- Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10Journal of Neuroimmunology, 1993
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- A new view of prostaglandin E regulation of the immune responseImmunology Today, 1991
- Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.The Journal of Experimental Medicine, 1990
- Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtypeCellular Immunology, 1989
- Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation.The Journal of Experimental Medicine, 1985
- Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic LesionsScience, 1983